Abstract
Systemic ketamine (50 or 160 mg/kg, i.p.) produced an antinociceptive effect in rats on the tail flick test. This effect of ketamine was inhibited by injection of naloxone (27 nmol) into the lateral ventricle. Intrathecal ketamine (3 μm) produced a slight but significant antinociceptive effect on the tail flick test, which was not affected by injection of naloxone (27 nmol) into the lateral ventricle. Antinociception was not produced by injection of ketamine into the lateral ventricle (3 μm) or the rostral ventromedial medulla RVM (30 nmol). The role played by spinal and supraspinal opioid receptors in ketamine-induced antinociception is discussed.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
